A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
暂无分享,去创建一个
A. Vercelli | J. Bogousslavsky | M. Repici | P. Clarke | D. Schorderet | C. Bonny | L. Hirt | T. Borsello
[1] H. Bading,et al. The Yin and Yang of NMDA receptor signalling , 2003, Trends in Neurosciences.
[2] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[3] D. Graham,et al. New Method for the Quantitative Assessment of Axonal Damage in Focal Cerebral Ischemia , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] David J Gladstone,et al. Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions , 2002, Stroke.
[5] M. Bogoyevitch,et al. Identification of the Critical Features of a Small Peptide Inhibitor of JNK Activity* , 2002, The Journal of Biological Chemistry.
[6] David W. Anderson,et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Chopp,et al. Extension of the Therapeutic Window for Recombinant Tissue Plasminogen Activator With Argatroban in a Rat Model of Embolic Stroke , 2001, Stroke.
[8] M. Moskowitz,et al. Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia , 2001, British journal of pharmacology.
[9] Elizabeth P. Garcia,et al. Kainate Receptor Activation Induces Mixed Lineage Kinase-mediated Cellular Signaling Cascades via Post-synaptic Density Protein 95* , 2001, The Journal of Biological Chemistry.
[10] A. Palmer,et al. A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke , 2001, Brain Research.
[11] C. Iadecola,et al. Cerebral ischemia and inflammation , 2001, Current opinion in neurology.
[12] Xiongwei Zhu,et al. Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease , 2001, Journal of neurochemistry.
[13] D. Schorderet,et al. Cell-Permeable Peptide Inhibitors of JNK: Novel Blockers of β-Cell Death , 2001 .
[14] P. Schauwecker. Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background , 2000, Brain Research.
[15] M. Dickens,et al. Dual Roles for c-Jun N-Terminal Kinase in Developmental and Stress Responses in Cerebellar Granule Neurons , 2000, The Journal of Neuroscience.
[16] D. Choi,et al. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. , 2000, Journal of neurotrauma.
[17] T Brott,et al. Treatment of acute ischemic stroke. , 2000, The New England journal of medicine.
[18] Guo-Yuan Yang,et al. Activation of Mitogen-Activated Protein Kinases After Permanent Cerebral Artery Occlusion in Mouse Brain , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[19] Y. Suh,et al. Carboxyl‐terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] D. Graham,et al. NMDA Receptor Blockade Fails to Alter Axonal Injury in Focal Cerebral Ischemia , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] J. Wettstein,et al. White matter ischaemia , 1999, Brain Research Reviews.
[22] S. Finkbeiner,et al. Sending signals from the synapse to the nucleus: Possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth , 1999, Journal of neuroscience research.
[23] S. Schwarze,et al. In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.
[24] M. Moskowitz,et al. Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.
[25] P. Rakic,et al. The Jnk1 and Jnk2 Protein Kinases Are Required for Regional Specific Apoptosis during Early Brain Development , 1999, Neuron.
[26] E. Wagner,et al. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation , 1999, Nature Genetics.
[27] M. Moskowitz,et al. Prolonged Therapeutic Window for Ischemic Brain Damage Caused by Delayed Caspase Activation , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[28] P. Han,et al. Ca2+‐Mediated Activation of c‐Jun N‐Terminal Kinase and Nuclear Factor κB by NMDA in Cortical Cell Cultures , 1998, Journal of neurochemistry.
[29] N. Neff,et al. Preservation of cholinergic activity and prevention of neuron death by CEP-1347/KT-7515 following excitotoxic injury of the nucleus basalis magnocellularis , 1998, Neuroscience.
[30] M. Moskowitz,et al. Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia , 1998, The Journal of Neuroscience.
[31] P. Rakic,et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene , 1997, Nature.
[32] Priscille Brodin,et al. A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.
[33] M. Moskowitz,et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[35] M. Karin,et al. Induction of c‐fos expression through JNK‐mediated TCF/Elk‐1 phosphorylation. , 1995, The EMBO journal.
[36] J. Méry,et al. The retro-inverso form of a homeobox-derived short peptide is rapidly internalised by cultured neurones: a new basis for an efficient intracellular delivery system. , 1995, Biochemical and biophysical research communications.
[37] C. Iadecola,et al. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. , 1995, The American journal of physiology.
[38] M. Moskowitz,et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.
[39] K. Hossmann. Glutamate‐Mediated Injury in Focal Cerebral Ischemia: The Excitotoxin Hypothesis Revised , 1994, Brain pathology.
[40] D. Steiner,et al. The new enzymology of precursor processing endoproteases. , 1992, The Journal of biological chemistry.
[41] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.